Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1990 1
1991 3
1992 4
1993 3
1994 9
1995 3
1996 5
1997 10
1998 14
1999 4
2000 11
2001 10
2002 10
2003 14
2004 7
2005 9
2006 15
2007 7
2008 8
2009 6
2010 12
2011 10
2012 7
2013 9
2014 11
2015 10
2016 13
2017 13
2018 8
2019 8
2020 13
2021 20
2022 15
2023 8
2024 6
2025 5
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

293 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Cunningham TJ, Tabacchi M, Eliane JP, Tuchayi SM, Manivasagam S, Mirzaalian H, Turkoz A, Kopan R, Schaffer A, Saavedra AP, Wallendorf M, Cornelius LA, Demehri S. Cunningham TJ, et al. J Clin Invest. 2017 Jan 3;127(1):106-116. doi: 10.1172/JCI89820. Epub 2016 Nov 21. J Clin Invest. 2017. PMID: 27869649 Free PMC article. Clinical Trial.
Here, we investigated the efficacy of calcipotriol, a topical TSLP inducer, in combination with 5-fluorouracil (5-FU) as an immunotherapy for actinic keratosis. METHODS: The mechanism of calcipotriol action against skin carcinogenesis was examined in genetically eng …
Here, we investigated the efficacy of calcipotriol, a topical TSLP inducer, in combination with 5-fluorouracil (5-FU) as an immunothe …
The therapeutic potential of calcipotriol in diseases other than psoriasis.
Holm EA, Jemec GB. Holm EA, et al. Int J Dermatol. 2002 Jan;41(1):38-43. doi: 10.1046/j.1365-4362.2002.01339.x. Int J Dermatol. 2002. PMID: 11895512
BACKGROUND: Calcipotriol is a vitamin D analog, which has antiproliferative and anti- inflammatory effects, and stimulates terminal differentiation. ...OBJECTIVE: To assess the clinical efficacy of topical calcipotriol in diseases other than psoriasis. RESULTS: A to …
BACKGROUND: Calcipotriol is a vitamin D analog, which has antiproliferative and anti- inflammatory effects, and stimulates terminal d …
Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.
Fenton C, Plosker GL. Fenton C, et al. Am J Clin Dermatol. 2004;5(6):463-78. doi: 10.2165/00128071-200405060-00012. Am J Clin Dermatol. 2004. PMID: 15663344
The two-compound product containing calcipotriol 50 microg/g plus betamethasone dipropionate 0.5 mg/g (Dovobet, Daivobet) [referred to here as calcipotriol/betamethasone dipropionate], is a topical treatment for psoriasis vulgaris, combining a vitamin D analog and a …
The two-compound product containing calcipotriol 50 microg/g plus betamethasone dipropionate 0.5 mg/g (Dovobet, Daivobet) [referred t …
Chinese herbal medicine bath therapy for psoriasis vulgaris using topical calcipotriol as the comparator: A systematic review with meta-analysis and association rule analysis.
Wang J, Zhang CS, Zhang AL, Changli Xue C, Lu C. Wang J, et al. J Ethnopharmacol. 2024 Aug 10;330:118166. doi: 10.1016/j.jep.2024.118166. Epub 2024 Apr 16. J Ethnopharmacol. 2024. PMID: 38621466
The findings of this review revealed that: 1) CHM bath therapy produced comparable effects to calcipotriol in reducing Psoriasis Area and Severity Index (PASI), Psoriasis Scalp Severity Index (PSSI), and itch visual analogue scale (VAS) at the end of the treatment phase; a …
The findings of this review revealed that: 1) CHM bath therapy produced comparable effects to calcipotriol in reducing Psoriasis Area …
The addition of topical calcipotriol to phototherapy enhance the efficacy of treatment in patients with vitiligo: A systematic review and meta-analysis.
Hu M, Liao K, Lei W, Zhang R, Tu C. Hu M, et al. Int Immunopharmacol. 2021 Sep;98:107910. doi: 10.1016/j.intimp.2021.107910. Epub 2021 Jun 28. Int Immunopharmacol. 2021. PMID: 34198237
BACKGROUND: Treatment of vitiligo has several challenges. Phototherapy and topical calcipotriol have been reported to be effective in combination with other therapies, but there is no consensus on the combination use. ...CONCLUSIONS: This meta-analysis provides evidence su …
BACKGROUND: Treatment of vitiligo has several challenges. Phototherapy and topical calcipotriol have been reported to be effective in …
Clinical efficacy and safety of using calcipotriol-betamethasone compounding agent for psoriasis treatment: a systematic review and meta-analysis.
Ren J, Zhu Q, Wang S, Li X, Sun Z, Li N, Feng J, Ding H, Dong S, Wang H. Ren J, et al. Arch Dermatol Res. 2022 Sep;314(7):633-641. doi: 10.1007/s00403-021-02272-5. Epub 2021 Aug 20. Arch Dermatol Res. 2022. PMID: 34417633

The results indicated that for short-term treatment, a sequential therapy that uses calcipotriol betamethasone compounding agent and calcipotriol improves PASI score (MD = -0.94, 95% CI - 1.38 ~ - 0.49, P < 0.0001, I(2) = 49%), comparing with using only calcip

…
The results indicated that for short-term treatment, a sequential therapy that uses calcipotriol betamethasone compounding agent and …
Investigating the efficacy of calcipotriol-acitretin combination therapy versus monotherapy protocols in psoriasis and its effect on serum inflammatory factors: a systematic review and meta-analysis.
Wang H, Deng T, Wang J, Bai X, Shen Y, Qiu Y. Wang H, et al. Eur J Med Res. 2025 Jun 20;30(1):501. doi: 10.1186/s40001-025-02700-6. Eur J Med Res. 2025. PMID: 40542385 Free PMC article.
This meta-analysis aimed to comprehensively evaluate the efficacy and safety of calcipotriol-acitretin combination therapy for psoriasis and investigate its effect on serum inflammatory factors. ...The results of this study show that the calcipotriol-acitretin combi …
This meta-analysis aimed to comprehensively evaluate the efficacy and safety of calcipotriol-acitretin combination therapy for psoria …
Calcipotriol ointment shows comparable efficacy to topical steroids in chronic hand eczema.
Juntongjin P, Pongprasert R. Juntongjin P, et al. Dermatol Ther. 2019 Jul;32(4):e12956. doi: 10.1111/dth.12956. Epub 2019 May 20. Dermatol Ther. 2019. PMID: 31070845 Clinical Trial.
Approximately 70% of the subjects reported more than 75% improvement with calcipotriol at the end of the treatment. Mild scaling and mild dryness were the most common reactions found with calcipotriol and desoximetasone, respectively. In conclusion, calcipotriol …
Approximately 70% of the subjects reported more than 75% improvement with calcipotriol at the end of the treatment. Mild scaling and …
Topical calcipotriol combined with phototherapy for psoriasis. The results of two randomized trials and a review of the literature. Calcipotriol-UVB Study Group.
Molin L. Molin L. Dermatology. 1999;198(4):375-81. doi: 10.1159/000018151. Dermatology. 1999. PMID: 10490297 Review.
In one study, 101 patients were treated with calcipotriol on one side and calcipotriol + UVB on the other side of the body (open study). ...There was a similar adverse event profile with either treatment. The addition of UVB to calcipotriol did not alter the …
In one study, 101 patients were treated with calcipotriol on one side and calcipotriol + UVB on the other side of the body (op …
293 results